Patients with data censored for survival will be indicated with a ‘+’ after the number of days. CEA data will be listed per patient. Table 1 3: Overall R esponse (Response Population) Overall Tumour Response No. of Patients N=XX irCR X (XX.X%) irPR irSD irPD NE Response rate (irCR + irPR) SM.TEMP.013 version 5 CRUKD/17/003 RAP Version: 2.0 09Mar2023 FINAL 20 Table 1 4: Summary of Survival (Safety Population) Patient Time to Death (or Last Contact) (days) XX/XXX N XX/XXX XX/XXX XX/XXX Median (range) X (X-X) Table 1 5: Two Year Survival (Safety Population) Patient s alive Patients deceased N (%) [ XX/XXX , XX/XXX …] N (%) [XX/XXX, XX/XXX… ] 5.10 General data conventions There is only one dose level for this study, as specified in the study protocol. Patients who deviate from the assigned dose and/or schedule will be clearly described in the CSR with regards to their treatment modification and if applicable in the list of protocol deviations ( Section 5.4).